Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases

Overview of attention for article published in Frontiers in immunology, April 2021

Altmetric Badge

About this Attention Score

Above-average Attention Score compared to outputs of the same age (53rd percentile)
Above-average Attention Score compared to outputs of the same age and source (54th percentile)

Mentioned by

twitter: 6 X users

Citations

dimensions_citation: 20 Dimensions

Readers on

mendeley: 40 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 6 X posts from 6 X users, with an upper bound of 14,121 followers.

"...there is only one ICP-targeted drug, Abatacept, approved for use in clinics, which indicates both the challenges and opportunities in the development these therapeutics." Interesting paper. https://t.co/xXERWCP8Pi

28 Apr 2024

Reply Repost Favourite

Interesting review revealing promise & complexities of CPI agonism for AID ! Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases. Front Immunol. doi: 10.3389/fimmu.2021.645699. PMID: 33968036; PMCID: PMC8097144. https://t

26 Nov 2022

Reply Repost Favourite

New 3i Investigator Article Alert!! Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases https://t.co/fFzGZP83YC #sciencetwitter #academictwitter

11 May 2021

Reply Repost Favourite

New article: Immune Checkpoints, a Novel Class of Therapeutic Targets for Autoimmune Diseases https://t.co/nFxB9hZH47 #MS #multiplesclerosis #neurology https://t.co/i2MA37rw0D

10 May 2021

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 2 additional X posts.